-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Legend Biotech, Maintains $50 Price Target

Benzinga·04/15/2026 11:41:40
Listen to the news
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Legend Biotech (NASDAQ:LEGN) with a Buy and maintains $50 price target.